ArticleBMC research notes2025
The NAC transcription factor ATAF2 enhances Arabidopsis biomass and chlorophyll a accumulations at the early growth stage.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveThe Arabidopsis thaliana NAC-family transcription factor ATAF2 plays extensive regulatory roles in plant disease resistance, abiotic stress tolerance, leaf senescence, hormone metabolism, and seedling photomorphogenesis. Using Arabidopsis seedlings as the investigation platform, we previously demonstrated that ATAF2 overexpression can increase the endogenous levels of the growth-promoting hormone brassinosteroids (BRs) and suppress the expression of the chlorophyll b (Chl-b) reductase NYC1, which catalyzes the initial step of the degradation of light-harvesting chlorophyll a/b-protein complex of photosystem II (LHCII). ATAF2 also promotes the expression of NIT2, which is involved in the biosynthesis of the auxin indole-3-acetic acid (IAA). Here, we further examined the effects of elevated BR/IAA levels and reduced NYC1 expression on biomass and Chl-a/b accumulations, respectively.
resultsTwelve-day-old plants were harvested for biomass and Chl-a/b measurements. While no significant difference of biomass or Chl-a/b accumulations was observed between the wild-type Col-0 and the loss-of-function ataf2-1/2 plants, all three ATAF2 overexpression lines (ATAF2ox-1/2/3) exhibited much higher biomass and Chl-a accumulations as compared to Col-0 and ataf2-1/2, which can at least be partially interpreted as the consequences of higher endogenous BR/IAA levels and reduced NYC1 expression, respectively. The results demonstrate the positive regulatory role of ATAF2 in biomass and Chl-a accumulations. Notably, ATAF2 overexpression does not increase Arabidopsis biomass accumulation at later growth stages, indicating its functional nature of developmental timing acceleration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.